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Size control is essential for all proliferating cells, and is thought to be regulated by checkpoints that couple cell size to
cell cycle progression. The aberrant cell-size phenotypes caused by mutations in the retinoblastoma (RB) tumor
suppressor pathway are consistent with a role in size checkpoint control, but indirect effects on size caused by altered
cell cycle kinetics are difficult to rule out. The multiple fission cell cycle of the unicellular alga Chlamydomonas
reinhardtii uncouples growth from division, allowing direct assessment of the relationship between size phenotypes
and checkpoint function. Mutations in the C. reinhardtii RB homolog encoded by MAT3 cause supernumerous cell
divisions and small cells, suggesting a role for MAT3 in size control. We identified suppressors of an mat3 null allele
that had recessive mutations in DP1 or dominant mutations in E2F1, loci encoding homologs of a heterodimeric
transcription factor that is targeted by RB-related proteins. Significantly, we determined that the dp1 and e2f1
phenotypes were caused by defects in size checkpoint control and were not due to a lengthened cell cycle. Despite
their cell division defects, mat3, dp1, and e2f1 mutants showed almost no changes in periodic transcription of genes
induced during S phase and mitosis, many of which are conserved targets of the RB pathway. Conversely, we found
that regulation of cell size was unaffected when S phase and mitotic transcription were inhibited. Our data provide
direct evidence that the RB pathway mediates cell size checkpoint control and suggest that such control is not directly
coupled to the magnitude of periodic cell cycle transcription.
Citation: Fang SC, de los Reyes C, Umen JG (2006) Cell size checkpoint control by the retinoblastoma tumor suppressor pathway. PLoS Genet 2(10): e167. DOI: 10.1371/
journal.pgen.0020167
Introduction
Size control is a fundamental property of proliferating
cells, but the mechanisms that maintain cell size are still
poorly deﬁned [1]. In budding and ﬁssion yeasts, size
checkpoints are thought to govern either the G1/S or G2/M
cell cycle transitions, preventing cells that have insufﬁcient
mass from continuing the cell cycle until they have grown to a
minimum threshold size [2]. In animal cells, there is evidence
for cell size checkpoint control [3–6], but the nature and
existence of size checkpoints in animals are still debated [7].
In all eukaryotes, there appears to be a fundamental
relationship between cell size and DNA content that is likely
to be involved in governing cell size, but the nature of that
relationship is still unknown [8].
Genome-wide screens have been carried out in budding
yeast, yielding a large set of mutations that affect cell size
[9,10], and similar screens were done with Drosophila tissue
culture cells using RNA interference (RNAi) [11,12]. Mutants
or RNAi knockdowns that alter growth rate or cell cycle
progression show size phenotypes in such screens, but these
phenotypes do not necessarily result from altered checkpoint
control. Not surprisingly, cell size appears subject to input
from multiple genetic pathways whose relative contributions
to a size checkpoint mechanism are still unclear.
The retinoblastoma (RB) tumor suppressor pathway is
conserved in most eukaryotic lineages, including animals,
plants, and green algae, but has been lost from yeasts and
other fungi. RB-related proteins interact with transcription
factor heterodimers in the E2F and DP families and are
thought to regulate cell cycle progression through the
transcriptional activation or repression of genes required
for S phase and mitosis [13–17]. Perturbation of RB pathway
proteins has been shown to affect cell size and cell cycle
control in animals and plants in a manner that is consistent
with loss of size checkpoint control: Animals or plants that
have lost RB or RB-related proteins usually have small cells
[18–21], and overexpression of RB results in larger cells [22].
It is not clear whether these effects are due to altered size
checkpoints or are caused by overall changes in cell cycle and/
or growth rates that override checkpoint control. Moreover, a
direct role for the RB pathway in size control is not precluded
by the existence of its well-established role as an integrator of
extracellular growth factor signals [15,23].
Chlamydomonas reinhardtii is a unicellular green alga that
contains single copy genes encoding homologs of RB, E2F,
and DP [24,25] and provides a simpliﬁed model for analysis of
the RB pathway. One additional Chlamydomonas protein,
E2FR1, has a single, highly diverged E2F-like DNA binding
domain but no other conserved domains, and its function is
unknown.
The C. reinhardtii multiple ﬁssion cell cycle is characterized
by a long G1 period during which cells can grow in size by
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checkpoint similar to Start in yeast or the restriction point in
animal cells that gates passage through the remainder of the
cell cycle. Cells that have passed Commitment will complete
the cell cycle, even if subsequent growth is stopped by the
withdrawal of light or nutrients, whereas pre-Commitment
cells will return to a G0 resting state if growth is halted
[26,27]. Different measurements in wild-type strains have
determined that a minimum cell size must be attained in
order to pass Commitment [25,26,28,29]. Post-Commitment
cells do not immediately initiate S phase, but instead remain
in G1 for an additional 5 to 10 h, where they can continue to
grow and then ﬁnally undergo a rapid series of (n) alternating
S phases and mitoses (S/M)n to produce 2
n daughters. A
critical aspect of size regulation occurs during S/M where
mother cell size—which can vary over a wide range depend-
ing on growth conditions—controls the number of S/M cycles
to produce a uniform size distribution of daughters [26,30].
Because S/M can occur in the absence of concurrent growth,
daughter cell size can be used as a direct gauge of cell size
checkpoint function [8].
The RB homologue in C. reinhardtii is encoded by the MAT3
locus. mat3 mutant cells pass Commitment at a prematurely
small size, remain in G1 for several hours after Commitment
(like wild-type cells), and then undergo supernumerous
divisions to produce daughters that are 25% to 35% the size
of wild-type daughters [25,31]. Thus, similar to its role in
animals and plants, MAT3/RB acts as a negative regulator of
cell cycle progression. While it was postulated to be involved
in cell size checkpoint control, it was not clear whether MAT3
acted through DP and E2F proteins and, if so, whether E2F
and DP controlled rate limiting steps in cell size regulation.
Here we identiﬁed bypass suppressors of an mat3 null allele
that have mutations in the Chlamydomonas DP1 and E2F1
genes. We found that dp1 null mutants had a large-cell
phenotype caused by an increased Commitment threshold
size and a failure to initiate enough rounds of division during
S/M, opposite to the size checkpoint phenotypes of mat3
mutants. Two classes of dominant e2f1 suppressors were
found that displayed different degrees of severity of cell cycle
and cell size phenotypes. Importantly, the suppression of mat3
by dp1 and e2f1 mutations was not due to a lengthened cell
cycle but rather to a defect in size checkpoint function.
Surprisingly, however, we found no signiﬁcant transcrip-
tional defects for periodically expressed cell cycle genes in
dp1, e2f1, or mat3 mutant strains. Moreover, we found that
inhibition of periodic cell cycle transcription had no effect
on the number of cell divisions carried out by either wild-
type or dp1 mother cells and no inﬂuence on daughter cell
size. These data suggest that the RB pathway controls size-
dependent cell division in a manner that is not quantitatively
linked to transcriptional output during cell division.
Results
Isolation and Characterization of mat3 Bypass Suppressors
To investigate the downstream targets of MAT3 that are
required for regulation of cell division, we carried out an
insertional mutagenesis screen for bypass suppressors of a
null allele, mat3–4 [25,32]. Approximately 20,000 insertion
lines were screened, from which 19 suppressors were isolated,
including 12 DP1 alleles and three E2F1 alleles, all of which
showed strong suppression: The dp1 mutants caused a large-
cell phenotype, while the e2f1 mutants restored cells to
approximately wild-type size (Figure 1A and Table 1). Four
partial suppressors were isolated that had a more modest
effect on mat3–4 cell size (unpublished data), and these
suppressors will be described elsewhere along with details of
the screen (S.-C. Fang and J. G. Umen, unpublished data). No
other strong suppressors were found, but there are likely to
be additional partial suppressors since none of those found
were allelic. Mutations in the E2FR1 locus were not recovered
in this screen.
Some of the DP1 alleles contained deletions that com-
pletely removed the locus and some surrounding DNA, while
two alleles contained insertions without any other detectable
alterations (Figures 1B and S1 and unpublished data).
Reference allele dp1–1 contains a 4.7-kb plasmid insertion
in the ﬁrst exon (Figures 1B and S1) that is predicted to block
production of a functional protein (Figure 1C). dp1–1
behaved indistinguishably from a deletion allele, dp1–3
(Figure S3 and unpublished data), and was used for most of
the experiments.
The three e2f1 suppressor mutants isolated in this screen all
contained insertions in the 39 end of the E2F1 gene (Figures
1D and S1) that would be predicted to allow production of a
C-terminally truncated protein that retains DNA binding,
dimerization, and Marked Box domains (Figure 1E). These
three E2F1 alleles—e2f1–1, –2, and –3—behaved identically,
and reference allele e2f1–1 (Figure 1D) was used for most of
the experiments. A fourth suppressor allele, e2f1–4, was
isolated fortuitously from a population of transformed mat3–
4 cells and contains an internal deletion that removes exon 5
and fuses parts of exons 4 and 6 in-frame (Figure 1D and see
Materials and Methods). The phenotype of e2f1–4 is described
in more detail below. Based on their repeated isolation, the
screen appears to be saturated for the DP1 and E2F1 loci.
Possible reasons for the absence of obvious e2f1 null alleles
are presented in the Discussion.
In principle, any mutation that slows cell cycle progression
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Size Control by the RB Pathway
Synopsis
All cell types have a characteristic size, but the means by which cell
size is determined remain mysterious. In proliferating cells, control
mechanisms termed checkpoints are thought to prevent cells from
dividing until they have reached a minimum size, but the nature of
size checkpoints has proved difficult to dissect. The unicellular alga
Chlamydomonas reinhardtii divides via an unusual mechanism that
uncouples growth from division, and thereby allows a direct
assessment of how different genetic pathways contribute to size
control. The retinoblastoma (RB) tumor suppressor pathway is a
critical regulator of cell cycle control in plants and animals and is
thought to act as a transcriptional switch for cell cycle genes, but it
had not been directly implicated in cell size checkpoint function.
The authors found that mutations in genes that encode key proteins
of the RB pathway in Chlamydomonas affect cell size and cell cycle
control by altering size checkpoint function. Unexpectedly, the
predicted transcriptional targets of the RB pathway were not
affected by the mutations, and blocking transcription did not alter
cell size control. These data link the RB tumor suppressor pathway
directly to size control and suggest the possibility that cell size and
cell cycle control by the RB pathway may not be coupled to its
transcriptional output.might increase cell size and suppress mat3–4. We therefore
carried out dark-shift assays to determine whether suppres-
sion of mat3–4 by dp1–1 and e2f1–1 was due to a slowed cell
cycle or due to a fundamental change in the size checkpoint
function that couples mother cell size to the proper number
of division cycles. Unsynchronized cultures of wild-type,
single, and double mutants were grown in continuous light to
generate a random distribution of cells and then shifted into
the dark for 16 to 18 h. Upon shifting to the dark, growth
ceases, and any cell that is past Commitment will enter S/M
phase (typically within 5 to 10 h for wild-type) and divide to
produce 2
n daughter cells. Given sufﬁcient time, even ‘‘slow’’
cell cycle mutants will eventually produce daughter cells of
the appropriate size [8,33]. However, the suppressed strains
always produced daughters whose sizes were larger than wild-
type for dp1–1 mat3–4 or similar to wild-type for e2f1–1 mat3–
4, regardless of how long they were dark shifted (Figure 2A,
Table 1, and unpublished data). These results indicated that
both dp1–1 and e2f1–1 suppressed mat3–4 by altering the size
checkpoint function that controls how many S/M cycles are
initiated rather than simply slowing cell cycle progression.
The cell cycle kinetics for dp1–1 and e2f1–1 are described
further below.
We also observed the cell cycle behaviors of dp1–1 and e2f1–
1 single mutants that were generated by outcrossing each
suppressed double mutant to a wild-type strain. We carried
Figure 1. Suppressors of mat3–4
(A) Nomarski images of daughter cells from indicated strains. Scale bar ¼ 10 lm.
(B, D) Schematic of DP1 and E2F1 loci, with exons and introns denoted by rectangles and solid lines, respectively. Translation start (ATG) and stop (TGA)
codons, and SmaI cut sites are shown. Plasmid insertion sites for dp1–1 and e2f1–1 alleles are indicated by dark triangles. The deleted region of e2f1–4
genomic DNA is indicated by a dashed line.
(C, E) Schematics of DP1 and E2F1 proteins showing DNA binding domains (red), dimerization domains (blue), and Marked box (green). The arrows
indicate the position where the e2f1–1 insertions would interrupt the peptide sequence. For E2F1–4, part of the predicted E2F1 protein is missing due
to an in-frame deletion as indicated.
DOI: 10.1371/journal.pgen.0020167.g001
Table 1. Growth Rate, Protein Content, Cell Size, and Commitment Size Threshold Data for Indicated Strains
Genotype Doubling Time (h) Protein Content (pg/cell) Modal Cell Size (lm
3) Median Cell Size (lm
3) Commitment Size (lm
3)
Wild-type 4.9 6 0.2 22 6 1.4 63 6 3.6 63 6 3.1 195 6 7
mat3–4 9.1 6 1.3 14 6 0.1 25 6 1.6 27 6 2.4 110
a
dp1–1 4.7 6 0.4 44 6 0.3 100 6 3.5 104 6 4.9 237 6 4
dp1–1 mat3–4 5.1 6 0.2 38 6 3.6 90 6 2.3 89 6 2.3 nt
e2f1–1 5.2 6 0.2 23 6 0.1 64 6 4.1 64 6 5.8 .195
e2f1–1 mat3–4 5.0 6 0.8 26 6 1.1 66 6 1.1 67 6 5.7 nt
e2f1–4 nt nt 110 6 11.6 108 6 10.6 nt
e2f1–4 mat3–4 nt nt 107 6 9.7 102 6 6.8 nt
Protein content, modal cell sizes, and median cell sizes were determined for cultures that were dark-shifted after growth in continuous light. Mass doubling time was determined for cells
growing exponentially in continuous light. Standard errors were derived from three independent cultures for doubling time analysis, two independent cultures for protein content
analyses, and four independent cultures for cell size. Note that dark-shifted mat3–4 cells have a broader size distribution than mat3–4 gametes that were used for previously published
measurements [25]. For Commitment size threshold determination, standard errors were derived from multiple time points in each of three independent experiments. See Results for
information on e2f1–1 Commitment size.
nt, not tested.
aThe mat3–4 Commitment size was measured in [25].
DOI: 10.1371/journal.pgen.0020167.t001
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Size Control by the RB Pathwayout dark-shifting experiments for each single mutant and
found that their daughter cell sizes were almost identical to
the corresponding double mutant strains with mat3–4 (Figure
2A and Table 1). This ﬁnding suggested that the dp1–1 and
e2f1–1 strains were largely insensitive to the presence or
absence of MAT3/RB and that the deregulated cell division
phenotypes of mat3–4 null strains were dependent on DP1
and E2F1. Based on their epistatic relationships with mat3–4,
the different daughter cell sizes of dp1–1 and e2f1–1 mutants
seemed somewhat paradoxical, but this difference is likely to
be caused by residual cell cycle activation that can occur in
e2f1–1 strains. This idea is elaborated further in the
Discussion.
We investigated the cell division behavior for each mutant
strain more directly by plating unsynchronized light-grown
cells on agar, shifting the plates to the dark, and then assaying
cell division for individual cells after dark incubation [25].
While post-Commitment mat3–4 cells almost always divided
at least two and sometimes up to ﬁve times under these
conditions, the suppressed strains had division numbers that
were closer to wild-type, with most committed cells dividing
either one or two times (Figure 2B and 2C). While the dp1–1
cell division numbers appeared similar to wild-type in these
experiments, they were abnormally low given the larger size
of dp1–1 or dp1–1 mat3–4 mother cells (Figure 2C and
unpublished data). Taken together, our data show that dp1
and e2f1 mutations block the ability of mat3 mutant cells to
initiate extra rounds of S phase.
Commitment is a cell size checkpoint that is also controlled
by the RB pathway in Chlamydomonas. mat3 mutants were
previously shown to pass Commitment at a smaller size than
wild-type cells [25], and we therefore asked whether dp1 or
e2f1 mutants also had altered Commitment cell size thresh-
olds. Commitment was measured in synchronous cultures so
that G1 populations with well-deﬁned size ranges could be
obtained. Synchrony for dp1 and e2f1 strains was much more
difﬁcult to achieve than for wild-type, but we were able to
synchronize the mutants using a modiﬁed light-dark regimen
that also worked for wild-type cells (see Materials and
Methods).
T h eC o m m i t m e n ts i z et h r e s h o l di nt h es y n c h r o n o u s
cultures was measured by removing aliquots of cells at
various times during G1 and determining their cell size
distributions before and after dark-shifting, and by plating
aliquots of cells on agar in the dark in order to more
accurately determine the fraction of committed cells (Figure
3). The data on cell size distribution and fraction of
committed cells were then combined to determine the
threshold size at which cells divide. For wild-type cultures,
as cells approached approximately 195 lm
3, they passed
Commitment and were capable of dividing after a dark-shift.
In other words, the fraction of cells that was larger than
Figure 2. e2f1 and dp1 Mutations Suppress mat3–4 Cell Division Phenotypes
(A) Cell size distributions of dark-shifted cultures from indicated strains.
(B) Nomarski images of postmitotic clusters from indicated strains. Scale bar ¼ 10 lm.
(C) Distribution of cell division numbers from dark-shifted post-Commitment cells of indicated genotype.
DOI: 10.1371/journal.pgen.0020167.g002
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Size Control by the RB Pathwayapproximately 195 lm
3 accurately predicted the fraction of
cells in the population that were committed (Figure 4A and
Table 1). The wild-type Commitment size we measured was
slightly larger than that previously reported of approximately
178 lm
3 [25], but this difference may be due to the method of
cell size measurement employed (Coulter Counter versus
microscopic) and is within the margins of error for such
measurements. Compared to wild-type, dp1–1 cells were
found to reach a larger size of approximately 237 lm
3 before
they could pass Commitment (Figure 4A and Table 1). Thus,
dp1–1 cells showed defects in both passing Commitment and
in regulating daughter cell size.
e2f1–1 mutants displayed an interesting behavior that we
uncovered in synchronous cultures but that was not readily
apparent in dark-shift assays using unsynchronized cultures.
As e2f1–1 cells reached wild-type Commitment size, they
divided much less readily, and if they divided, produced large
daughters compared with wild-type cells (Figure 4B, left).
However, as the cells continued to grow and reached sizes
well above wild-type Commitment size, they could produce
daughters similar in size to wild-type daughters (Figure 4B,
right). Thus, e2f1–1 mutants had an increased Commitment
size, and cells that were just past Commitment also appeared
to have defects in daughter cell-size control. However, the
daughter cell-size defect disappeared as cells grew larger and
the entire population became committed. While e2f1–1
mutants clearly had a larger Commitment size than wild-
type, measuring their Commitment size proved difﬁcult.
Unlike wild-type and dp1–1 cultures, synchronized e2f1–1
cultures behaved somewhat unpredictably, sometimes passing
Commitment just above the threshold size of wild-type cells
and sometimes considerably later. This instability suggested
that e2f1–1 cells had a more severe defect early in the cell
cycle but that this defect could be partially overcome with
continued growth. However, it is important to note that the
supernumerous cell divisions of mat3–4 were effectively
suppressed by e2f1–1 under all circumstances, meaning that
even the apparently normal S/M cycles seen in e2f1–1 strains
concealed an underlying defect.
Complementation and Dominance Testing
We attempted to complement the dp1–1 and e2f1–1 strains
in order to conﬁrm that the mutant phenotypes we observed
were due to defects in each of these loci. To complement dp1–
1, we started with a dp1–1 mat3–4 strain and transformed in a
genomic construct containing the wild-type DP1 gene (gDP1).
Several gDP1 transformants had an mat3–4–like cell size
distribution, indicating that the dp1–1 suppressor phenotype
had been complemented (Figure 5A and 5B). The comple-
mented strains were then crossed to a wild-type strain to
conﬁrm linkage of gDP1 to the complemented phenotype
and to segregate it away from mat3–4. All the mat3–4 dp1–1
progeny from the cross that also had gDP1 were tiny, whereas
all those that did not receive gDP1 were large (unpublished
data). Moreover, all the dp1–1 single mutant progeny that
received gDP1 were wild-type in size, whereas those that did
not receive gDP1 were large (Figure 5C). Finally, there were
no size differences among wild-type progeny regardless of
whether they received the gDP1 construct (unpublished data).
These data conﬁrm that loss of DP1 is responsible for
suppressing mat3–4 and for causing the large-cell phenotype
that we observed in dp1 mutant strains. The transformation
experiments also showed that increased dosage of DP1 in a
wild-type strain has no obvious phenotype.
Unlike the case for dp1–1, we were unable to complement
e2f1–1, suggesting that it might encode a dominant allele
whose gene product cannot interact with MAT3. This
explanation is conceivable since the insertion that interrupts
the sequence of e2f1–1 occurs downstream of the region
encoding its DNA binding, dimerization, and Marked Box
domains and upstream of the region that encodes an RB-
interacting domain in other E2F proteins (Figure 1D and 1E).
Indeed, we found that an mat3/mat3 e2f1–1/E2F1 diploid strain
was similar in size to a wild-type diploid strain (approx-
imately 2-fold larger than a wild-type haploid) and was not
the size of an mat3/mat3 E2F1/E2F1 diploid strain as would be
expected if e2f1–1 were recessive to E2F1 (Figure 6A). The fact
that the three e2f1 mutants we isolated had less severe cell size
phenotypes than the dp1 mutants suggests that the mutant
E2F1 proteins retain some residual ability to activate the cell
cycle. This residual activity was dependent on the presence of
DP1 since e2f1–3 dp1–1 and e2f1–1 dp1–2 mutants were
identical in size to dp1–1 single mutants (Figure 6B and
unpublished data). The lack of synergistic or additive genetic
interactions between e2f1–1 and dp1–1 suggests that they act
together or on a common set of targets to suppress mat3–4.
Figure 3. Schematic Illustration of Commitment Size Threshold Assay
The light/dark phases of synchronized cultures are indicated by the
white and black bar on top. Aliquots of G1 cells are removed at different
times (t1,t 2,t 3,t 4), for size measurements (schematized in top row), and
for dark-incubation in liquid and on plates. The dashed vertical line
labeled CST represents a potential Commitment Size Threshold. After
dark-incubation for 18 to 24 h in liquid, the daughter cell size distribution
is measured (schematized in lower set of size distribution curves). The
light-colored dashed curve represents the size distribution prior to the
dark shift, and the dark solid line represents the cell size distribution after
dark shifting and cell division. The aliquot of cells that was incubated on
plates in the dark was scored microscopically to determine the fraction of
committed cells in the population. The arrowhead in the picture inset
indicates a cell that was not committed, and the stars indicate cells that
were committed and divided either once or twice to produce two and
four daughters, respectively. The CST is empirically determined by
finding a size threshold value that best explains the behavior of the cells
with respect to the fraction that were committed in each sample. The
reliability of this value is reflected in the standard error (see Table 1).
DOI: 10.1371/journal.pgen.0020167.g003
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Size Control by the RB PathwayIn order to better establish the dominant nature of
truncated E2F1 alleles, we took advantage of a fortuitously
isolated allele, e2f1–4, that arose in an mat3–4 strain during a
transformation experiment (see Materials and Methods).
Similar to the other E2F1 alleles, the protein encoded by
e2f1–4 is predicted to lack most its C-terminal sequence; but
unlike the other three alleles, the predicted e2f1–4-encoded
protein is also missing part of its Marked Box, a conserved
domain in E2F proteins that is adjacent to the dimerization
domain, and which mediates interaction with both RB-
related proteins [34,35] and with co-factors [36–40] (Figure
1D and 1E). e2f1–4 has a more severe cell size defect than
e2f1–1, –2, and –3, producing large daughters that are similar
in size to dp1 daughter cells (Figure 6C). However, like the
other three E2F1 alleles, e2f1–4 does not show any genetic
interactions with dp1–1 and is completely epistatic to mat3–4
(Figure 6C).
We constructed a genomic library from the e2f1–4 strain
and subcloned an approximately 4-kb fragment that contains
the e2f1–4 allele. The e2f1–4–containing construct was then
reintroduced into an mat3–4 strain by transformation.
Whereas in a control transformation with an empty vector,
no suppressed transformants were identiﬁed, several of the
mat3–4 transformants that received an e2f1–4 construct had a
suppressed, large-cell phenotype, similar to the original e2f1–
4 strain. Two such suppressed transformants were crossed to
a wild-type strain, and the progeny were scored for their size
phenotypes. We found that all the mat3–4 progeny that
received the e2f1–4 transgene construct showed a large-cell
phenotype, whereas the mat3–4 progeny that had no e2f1–4
transgene were small (Figure 6D). Interestingly, progeny that
were wild-type for MAT3 and had an e2f1–4 transgene also
had a large-cell phenotype (Figure 6D). These transformation
experiments demonstrate directly that truncated e2f1 alleles
can dominantly suppress mat3–4 and that such alleles can also
interfere with size control in a wild-type strain, generating a
large-cell phenotype.
Cell Cycle Transcription in dp1, e2f1, and mat3 Mutants
In C. reinhardtii, mRNA levels of cell cycle regulators as well
as genes involved in DNA synthesis are transcribed periodi-
cally, with peak expression occurring during S/M [24]. We
therefore tested whether induction of these periodically
expressed genes was altered in mutant strains (Figures 7 and
8). Based on work in other organisms, we predicted decreased
transcript levels in dp1 mutants, increased transcript levels in
mat3 mutants, and decreased or absent transcriptional
periodicity in all the mutants.
During synchronous growth, the mutant strains remained
in G1 for a shorter time than wild-type, entering S/M 2 to 4 h
earlier (Figure 7A, 7B, 7D, 7E, 7G, 7H, 7J, 7K, 7M, and 7N), but
like wild-type, all mutants remained in G1 for several hours
after passing Commitment and before initiating S/M (Figure
7B, 7E, 7H, 7K, and 7N). Importantly, dp1 and e2f1 mutants
completed the S/M phase within 3 to 4 h, similar to wild-type
cells (Figure 7A, 7B, 7D, 7E, 7G, 7H, 7J, 7K, 7M, and 7N),
indicating that they were not severely impaired in progress-
ing through S phase and mitosis.
Figure 4. Commitment Experiments with Synchronized Wild-Type, dp1–1, and e2f1–1
(A) Size distributions of synchronized cells growing in the light (dashed lines) and after dark-shifting (ds) (solid lines) for wild-type (black lines) and dp1–
1 (blue lines) cultures at two different times during G1 (left and right panels). In the left panel, the preshifted cells have a modal size of approximately
200 lm
3, and in the right panel, they have a modal size of approximately 400 lm
3.
(B) Size distributions of synchronized cells growing in the light (dashed lines) and after dark-shifting (ds) (solid lines) for wild-type (black lines) and e2f1–
1 (yellow lines) cultures at two different times during G1 (left and right panels). In the left panel, the preshifted cells have a modal size of approximately
200 lm
3, and on the right panel, they have a modal size of approximately 400 lm
3.
DOI: 10.1371/journal.pgen.0020167.g004
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Size Control by the RB PathwayThe availability of synchronous cultures of dp1 and e2f1
mutants allowed us to measure kinetics of periodically
expressed cell cycle genes. We chose genes that matched
several criteria, including strong periodic expression during
S/M [24], conservation as E2F targets in plants and/or animals
[15,41–43], and the presence of one or more potential E2F
consensus sites near the predicted transcription start site [44].
These genes included ribonucleotide reductase (RIR1), PCNA
(PCN1), DNA primase (POLA4), cyclin A (CYCA1), cyclin B
(CYCB1), CDKB (CDKB1), CDC6, MCM2, and histone H4 (HFO)
(a multicopy gene family). With the exception of histone H4
(no site found) and CDKB1 (approximately 800 base pairs
upstream), each of these genes has at least one consensus E2F
binding site within 400 base pairs of its predicted transcrip-
tional start site (unpublished data) and could be a target of
the pathway.
In synchronous wild-type cultures, these cell cycle genes
were repressed during G1 and induced by as much as 100-fold
during S/M (Figures 7C and S4). Unexpectedly, a similar
pattern of repression and induction was observed in dp1 and
e2f1 strains alone or in combination with mat3–4, with peak
expression levels comparable to what was observed for wild-
type (Figures 7F, 7I, 7L, 7O, and S4). Thus, despite their
defects in initiating the correct number of S phases, dp1
mutants showed no defects in inducing or repressing the
transcriptional program that accompanies S/M. Moreover,
dp1 and e2f1 mutants did not display any delay in initiating S/
M phase after passing Commitment (Figure 7D, 7E, 7G, 7H, 7J,
7K, 7M, and 7N) as might be expected if rate-limiting
transcripts were slow to accumulate. On the contrary, the
dp1–1 and e2f1–1 cultures entered S/M slightly earlier than the
wild-type culture. In summary, the dp1 and e2f1 mutant
strains showed slightly altered G1 cell cycle kinetics compared
to wild-type but initiated and completed S/M at a similar rate
to wild-type, with an apparently normal transcriptional
program for all genes that were tested.
mat3–4 single mutants could not be synchronized by the
methods used for the other strains, so in parallel with a wild-
type strain, we induced partial synchrony by dark-shifting a
continuous-light culture, followed by a return to continuous
light [25]. Under these conditions, entry into S/M phase was
less synchronous than it was for the diurnally cycled cultures,
with the peak mitotic index for wild-type at approximately
38% and for mat3–4 at approximately 18% (Figure 8A, 8B,
8D, and 8E). For both wild-type and mat3–4 cells, the G1
repression of periodic cell cycle transcripts was less pro-
nounced than in highly synchronous cultures (Figure 8C, 8F,
and S5), suggesting that tight transcriptional control during
G1 is not critical for regulating cell cycle progression. While
messages for some cell cycle genes in mat3–4 strains were
slightly elevated compared to wild-type (Figures 8C, 8F, and
S5), overall the effect of the mutation on cell cycle gene
transcription was modest and unlikely to account for the
severe loss of replication control displayed by mat3–4
mutants.
Figure 5. Complementation of dp1–1
(A) Nomarski images of dp1–1 mat3–4 double mutants with and without a complementing genomic construct containing the wild-type DP1 gene
(gDP#1). Top panels show dark-shifted cells, and bottom panels show postmitotic clusters. Scale bar ¼ 10 lm.
(B) Size distributions of dark-shifted cells from mat3–4, dp1–1 mat3–4, and two independently generated dp1–1 mat3–4 transformants that are
complemented with gDP1 (gDP#1 and gDP#2).
(C) Size distributions of dark-shifted wild-type, dp1–1, and complemented dp1–1 (gDP#1) strains.
DOI: 10.1371/journal.pgen.0020167.g005
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and dp1 Mutants
Our results showing little difference in periodic cell cycle
transcription with RB pathway mutants suggested that their
underlying defects might not be linked to S/M transcription
levels. Therefore, in order to test more broadly whether any
periodically transcribed genes were important for determin-
ing the number of rounds of replication during S/M, we used
the RNA polymerase II inhibitor a-amanitin (Figure 9). We
treated a synchronized culture of wild-type cells in mid-G1
(post-Commitment) with 10 lM a-amanitin, a dose that was
sufﬁcient to completely block cell proliferation within one or
two generations (unpublished data). At this dose, a fraction
(10% to 20%) of the drug-treated cells failed to enter S/M
(Figure 9C), suggesting that initiation of the S/M program
depends on accumulation of a limiting transcript(s). The
progression of the remaining cells through S/M was delayed
slightly by a-amanitin (Figure 9A), but, importantly, despite
decreased cell cycle transcription (Figure 9B), the daughter
cell-size proﬁle of the a-amanitin–treated culture was
essentially identical to that of the control cells (Figure 9C,
lM amanitin). This experiment suggested that the program
which determines how many rounds of S phase are initiated
within each cell cycle and which is controlled by the MAT3/
RB pathway is insensitive to the message levels of cell cycle
transcripts.
We also compared the dose response of wild-type and dp1–
1 cells to a-amanitin, reasoning that if dp1–1 mutants were
limiting for S phase transcription, then their daughter cell-
sizes would be particularly sensitive to the drug. We
administered different doses of a-amanitin to synchronous
wild-type and dp1–1 cultures in mid-G1 and then observed
the size distribution of daughter cells at the end of the dark
period. Like wild-type, the decision to enter S/M was sensitive
to a-amanitin in dp1–1 strains, but once they entered the
replication phase of the cell cycle, the a-amanitin–treated
dp1–1 cells completed the same number of divisions as
untreated cells, and produced daughters whose size proﬁles
were essentially the same as untreated dp1–1 (Figure 9C and
9D). Therefore, S/M transcription does not appear to be rate
limiting for S phase control, even in dp1 mutants.
The MAT3/RB pathway also controls passage through
Commitment, but because administration of a-amanitin
blocks some subsequent cell division, we did not attempt to
assess its effects earlier in the cell cycle. mat3–4 single mutant
strains were found to respond to low doses of cytotoxic
agents (e.g., actinomycin, zeocin, methyl methanesulfonate)
by producing slightly larger daughters (unpublished data), but
these effects were not dosage sensitive and instead may reﬂect
a stress response. This response was not seen in dp1 or e2f1
strains but dissuaded us from further drug testing with mat3–
4 mutants.
Discussion
The Genetic Architecture of the RB Pathway in
Chlamydomonas
The RB pathway is found in several eukaryotic groups,
including animals and plants, whose last common ancestor
Figure 6. Dominance Testing and Genetic Interactions of e2f1 Mutants
(A) Size distributions of dark-shifted vegetative diploids of indicated genotype.
(B) Size distributions of dark-shifted wild-type, e2f1–3, dp1–1, e2f1–3 dp1–1, and e2f1–3 dp1–1 mat3–4 strains.
(C) Size distributions of dark-shifted wild-type, dp1–1, e2f1–4, e2f1–4 mat3–4, e2f1–4 dp1–1, and e2f1–4 dp1–1 mat3–4 strains.
(D) Size distributions of dark-shifted wild-type and mat3–4 with and without a transgenic e2f1–4 allele (te2f1–4).
DOI: 10.1371/journal.pgen.0020167.g006
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RB is a negative cell cycle regulator in Chlamydomonas were
consistent with the idea that the cell cycle regulatory function
of the RB pathway was already established prior to the
formation of the current major eukaryotic taxa [25]. Here we
have shown that the key targets of MAT3/RB-mediated cell
cycle activation are homologs of E2F and DP. While this
ﬁnding may seem obvious in retrospect, it provides the
strongest evidence to date for the common origin and
functional conservation of the RB pathway in an ancestral
eukaryotic lineage. It also establishes Chlamydomonas as a
simple, unicellular model for the RB pathway.
The RB pathway is clearly essential for development in
plants and animals, but one critical question that our work
addresses is whether E2F-DP activity has an essential cell-
autonomous role in driving the cell cycle. In Drosophila, some
larval development and cell cycle progression can occur in
DP mutants [46,47], but it is not clear to what extent maternal
stores of protein might allow mutant larval cells to cycle. In
mammalian cells, the activity of E2F1, E2F2, and E2F3 was
proposed to be required for proliferation [48], but this
requirement may be based on an imbalance caused by loss of
positive but not negative E2Fs [49]. In C. elegans, the RB
pathway appears to be primarily required for developmental
Figure 7. Cell Cycle Kinetics and Gene Expression Patterns in Synchronized Wild-Type and Mutant Strains
(A, D, G, J, M) FACS profile showing the DNA content of different genotypes during cell cycle progression. Note that postmitotic clusters often remain
together after division and account for the persistence of multiple peaks in some strains.
(B, E, H, K, N) Graphs showing passage through Commitment (black diamonds with dashed lines) and mitotic index (black circles with solid lines) of
synchronous cultures. Wild-type cultures entered S/M phase at approximately 13 h. Cultures of dp1–1, dp1–1 mat3–4, e2f1–1, and e2f1–1 mat3–4 passed
Commitment and entered the S/M phase earlier.
(C, F, I, L, O) Expression of S/M phase markers CDKB1 and POLA4 by quantitative RT-PCR. Insets show rescaled graphs to visualize expression at early time
points. The light/dark phases are indicated by white or dark bars above the graphs. Expression was normalized to the cytoplasmic 18S rRNA signal in
each sample. Data are from technical triplicates and presented as mean normalized units 6 SEM.
DOI: 10.1371/journal.pgen.0020167.g007
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cell cycle [50,51]. Based on genetic interactions in other
species and on our own genetic and in vitro data (K. Bisova
and J. G. Umen, unpublished data), DP1 and E2F1 function as
heterodimers, and loss of DP1 is expected to eliminate E2F1
activity. Although it is difﬁcult to completely rule out
redundancy, our data are most simply interpreted as E2F1-
DP1 heterodimers having a nonessential role in cell cycle
progression, but a critical role in maintaining size homeo-
stasis.
However, it is formally possible that other E2F-like genes
exist in Chlamydomonas that compensate either for loss of DP1
or dominant mutations in E2F1, but several observations
suggest that this is not the case. First, in the current and all
previous Chlamydomonas genome assemblies, extensive bio-
informatic searching has never identiﬁed any E2F or DP
family members other than those already described [24].
Second, no other copies of E2F1 or DP1 were detected by low
stringency Southern blotting (Figure S2). Third, a compre-
hensive search of the closely related Volvox carteri genome
revealed single orthologs of Chlamydomonas E2F1, DP1, and
E2FR1, but no additional E2F/DP family members (unpub-
lished data). While it has some resemblance to E2F/DP like
proteins, E2FR1 appears to be a poor candidate for an E2F1
or DP1 substitute—its DNA binding domain is diverged, and
it contains no obvious dimerization domain. Nonetheless, it
may be able to substitute in some way for the loss of DP1 or
dominant mutation in E2F1. If it did so (either as a binding
partner or in some other way), then we might have expected
to see added phenotypic severity when dp1 and e2f1 mutations
were combined, but that was never the case. We are currently
attempting to isolate null alleles of E2F1 and RNAi lines for
E2FR1 so that this question can be resolved more conclu-
sively.
Two unusual aspects of the suppressor screen were the high
rate of isolation of both DP1 and E2F1 alleles (12 of 20,000
and three of 20,000, respectively), and the absence of e2f1 null
mutations. If insertions were random, then they would occur
on average every 5 kb among 20,000 mutants (for an
approximately 100-Mb genome) and should have generated
one allele each for DP1 and E2F1. Thus, both the DP1 and
E2F1 loci appear to be hotspots for insertions/deletions.
Whether this insertion bias is also present in a wild-type
strain background is not known. It is notable that all the E2F1
insertions we identiﬁed were in a 1.4-kb SmaI fragment
(Figures 1D and S1) and that e2f1–4 resulted from a
spontaneous deletion in the same region (Figure 1D). While
it is possible that E2F1 is essential, our lack of null alleles in
the screen cannot be taken as evidence that this is the case
since the locus was highly susceptible to mutations in the 39
region that caused a dominant suppressor phenotype.
The structure of the E2F1 alleles that we isolated is
consistent with them acting as dominant negatives. As has
been observed elsewhere, C-terminally truncated alleles of
E2F can interfere with E2F function in mammalian cells [52].
Interestingly, a similar allele from Drosophila, de2f
i2, has
transcriptional defects [53] and can suppress the loss of the
ﬂy RB homolog, RBF1 [46], but is recessive [53]. The complete
dominance we observed for Chlamydomonas E2F1 suppressor
alleles could be due to enhanced stability of the mutant E2F1
proteins or mRNA compared to wild-type, but this remains to
be determined.
While the C-terminal region of Chlamydomonas E2F1 lacks
an obvious RB binding domain that is found on other E2Fs
[49,54,55], we propose that it encodes an alternative motif
that interacts with MAT3/RB. We also propose the existence
of a residual cell cycle activation function in heterodimers
formed between e2f1–1, 2, 3 encoded proteins and DP1 that
generates a partially functioning size control mechanism. The
mutant heterodimers may, for example, allow the slow
Figure 8. Cell Cycle Kinetics and Gene Expression in Partially Synchronized Cultures of Wild-Type and mat3–4
The light/dark phase is indicated by white or dark bars above the graphs.
(A, D) FACS profile showing the DNA content of wild-type and mat3–4 strains that were dark shifted and returned to continuous light.
(B, E) Graphs show Commitment (black diamonds with dashed lines) and mitotic index (black circles with solid lines) of the cultures. Both wild-type and
mat3–4 cultures entered S/M phase at approximately 8 to 10 h after return to the light and reached a mitotic peak at approximately 14 to 16 h.
(C, F) Expression of S/M phase markers CYCA1, CDKB1, and POLA4 by quantitative RT-PCR as described in Figure 7.
DOI: 10.1371/journal.pgen.0020167.g008
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large mother cells this activity is sufﬁcient to support a
normal number of S/M cycles. At the same time, this class of
E2F1 alleles must also limit the excess rounds of replication
and division that occur in mat3 mutants, perhaps by
restricting the overaccumulation of the same rate-limiting
activity that occurs when MAT3/RB is missing.
The RB Pathway and Cell Size Control
Our genetic results demonstrate a role for DP1-E2F1 and
MAT3/RB as positive and negative regulators of the cell cycle,
respectively, that affect cell size in opposite ways. While this
observation might be construed as a trivial outcome of
shortened or lengthened cell cycles, this is not the case. In
Chlamydomonas, the effects on cell size checkpoints can be
uncoupled from cell cycle kinetics, and the results we
obtained clearly implicate the RB pathway in cell size
checkpoint control. As previously observed, mat3 cells pass
Commitment prematurely and then divide too many times
during S/M [25]. Here, we showed that dp1 and e2f1 mutants
have the opposite phenotype of mat3, passing Commitment at
a larger size and exiting S/M prematurely before an adequate
number of cell divisions have been completed. Moreover, dp1
mutants did not appear to remain in S/M for an unduly long
period of time, and they were not slow to transition from G1
into S/M; on the contrary, dp1 mutants spent less time in G1
than wild-type cells. Nonetheless, dp1 cells maintained a large
size because they failed to initiate enough rounds of S phase.
Therefore, the effects we saw on cell size in RB pathway
mutants were due to aberrant cell size checkpoint control
and were not caused by a slow cell cycle.
The fact that cells missing key components of the RB
pathway can still maintain size equilibrium, albeit at
abnormal sizes, indicates that there are alternative mecha-
nisms that can contribute to cell size homeostasis. Therefore,
the rate-limiting factors that are required for cell cycle
progression can be produced in cells that are mutant for
MAT3, E2F1, or DP1, but perhaps they are produced at the
wrong time and/or in inappropriate quantities. The unstable
behavior of the e2f1–1 strain in passing Commitment suggests
that it is on the ‘‘borderline’’ for production of such a factor,
but once made, it can modulate proper cell division later on
in the cell cycle. It is important to note that our assay for
Commitment is based operationally on future cell division
behavior and is not based on a real-time molecular assay such
as presence/absence of a protein modiﬁcation or production/
localization of a protein or RNA. Understanding the
molecular details of Commitment and the regulation of cell
division number will be critical for truly understanding how
the RB pathway mediates cell size control.
The cell size phenotypes we saw for RB pathway mutants in
Chlamydomonas are similar to the cell size phenotypes of
animal and plant cells that have perturbations in the RB
pathway [18–21,56,57], but it might be argued that they arise
for different reasons—altered size checkpoint control in
Chlamydomonas versus altered cell cycle kinetics in other
organisms. However, the two explanations are not mutually
exclusive: Size checkpoint defects in a canonical cell cycle
would be expected to alter the overall cell cycle phasing.
However, in developing systems, the RB pathway is integrated
with developmental control mechanisms at a number of
levels, including responses to extracellular signaling path-
ways, regulation of growth rates, and apoptosis
[16,17,23,58,59]. The cell size and developmental phenotypes
of an RB mutation in Dictyostelium, a primitive slime mold that
interconverts between a unicellular and multicellular form,
Figure 9. Cell Division in the Presence of RNA Polymerase II Inhibitor a-Amanitin
(A) a-Amanitin 10 lM was added to 12:12 light/dark synchronized wild-type cells at 9 h in the light period (vertical arrow), and the drug-treated or
control cultures were dark-shifted at 10 h. The cells stayed in the dark for the remainder of the experiment. The mitotic index was measured for each
culture as indicated.
(B) Quantitative RT-PCR of S/M phase markers CDKB1, PCN1, and POLA4 from control and a-amanitin–treated cultures at different times.
(C, D) Dose response of synchronized wild-type (C) or dp1–1 (D) cells treated with different concentrations of a-amantin prior to cell division. Mother cell
size distribution is shown by the black curve (pretreatment), and postmitotic daughter cell sizes produced in different concentrations of a-amantin by
the different color curves.
DOI: 10.1371/journal.pgen.0020167.g009
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transition to multicellularity [60]. These additional devel-
opmental roles do not preclude the participation of the RB
pathway in a size checkpoint, but they make the identiﬁcation
of its function as a size regulator more complicated. In
animals there has been compelling evidence for a G1-S size
checkpoint [3,61] although it may not operate in all cell types
[7]. It will be interesting to determine whether the G1 size
control that has been observed in animal cells operates
through the RB pathway. It is also intriguing that in budding
yeast, which has lost the RB pathway, a highly similar genetic
mechanism has evolved to control progression through Start,
a G1-S size checkpoint [62,63]. In summary, the role we have
identiﬁed for the RB pathway in size regulation may
represent a basal function that evolved in unicellular
organisms, to which was added additional regulatory inputs
in multicellular species.
Transcriptional Regulation by the RB Pathway in
Chlamydomonas
While the genetic architecture of the RB pathway has been
conserved in Chlamydomonas, its inﬂuence on cell cycle
transcription has not. The regulation of predicted targets of
E2F was not altered signiﬁcantly in RB pathway mutants, and
inhibition of transcription did not inﬂuence cell division
number. These ﬁndings were surprising because many of the
transcriptional targets of E2F are conserved between plants
and animals [15,41–43]. However, E2F may be bound at many
noncanonical sites [64], so predicting targets based on E2F
consensus sites may be an inadequate method for identifying
E2F-regulated genes. The transcriptional output of the RB
pathway usually correlates with cell cycle progression
[14,16,17,49,65], but it should be noted that any increase or
decrease in the rate of cell cycle progression mediated by
changes in RB-E2F activity will indirectly inﬂuence levels of
cell cycle regulated messages, whether or not they are direct
transcriptional targets of E2F. Thus, in asynchronous culture
systems it is easy to overestimate the direct inﬂuence of the
RB pathway on cell cycle transcription. Our ability to
synchronize mutant cells allowed us to overcome this
problem by examining periodic transcription within a single
cell cycle.
It is possible that our experiments were unable to detect a
role for E2F1-DP1–mediated transcription in Chlamydomonas.
Given that RB pathway mutants have defects at Commitment
and during S/M, it is possible that the key transcriptional
response is for target genes that are activated early in the cell
cycle and that these defects carry over into S/M. Another
possibility is that the RB pathway does not control the
magnitude of cell cycle transcription but its relative timing.
In this model, the duration of the transcriptional burst
during S/M but not its magnitude would determine cell
division number. In other words, the RB pathway would
control the window of time during which a cell could initiate
S phase and mitosis but would not directly control the
induction of S/M-regulated transcripts. In mat3 mutants, the
window would be abnormally lengthened, and in dp1 mutants,
it would be shortened. In any case, our ﬁndings do show that
the magnitude of S/M transcription does not predict cell
division behavior and is not controlled by the RB pathway.
This conclusion also implies the existence of an alternative
cell cycle transcription mechanism that can induce and
repress expression of S/M genes in Chlamydomonas independ-
ently of the RB pathway.
Despite lacking obvious transcriptional phenotypes, mu-
tants in the RB pathway have very clear cell cycle phenotypes.
This discrepancy has prompted us to consider alternative
possibilities for how the RB pathway might control the cell
cycle. It is conventionally believed that the transcriptional
induction of cell cycle genes by E2F-DP complexes has a
primary causative role in promoting cell cycle progression.
However, the deﬁnitive identiﬁcation of rate-limiting E2F
targets is not easy, with the Drosophila cyclin E gene being one
of few examples [66,67]. Until recently, mammalian cyclin E
was also thought to be such a target, but results showing that
cyclin E and its binding partner, CDK2, are not essential for
cell cycle progression have demonstrated that this is not the
case [68–70]. Moreover, there is evidence from Drosophila that
cell cycle progression and transcription of E2F targets do not
always correlate [46,47]. It is, therefore, possible that the
primary role of the MAT3/RB pathway in regulating cell cycle
progression may not be related to transcription. In this
scenario, the RB pathway would activate S phase through
some other mechanism, and while we have not identiﬁed such
a mechanism, there is intriguing evidence suggesting non-
transcriptional roles for RB in other organisms. For example,
in Drosophila, RB complexes have been proposed to regulate
chorion gene ampliﬁcation through direct interaction with
origin recognition complexes in a manner that is insensitive
to transcriptional inhibition [53,71]. RB has also been found
to inﬂuence DNA replication in Xenopus cell-free extracts by
interaction with the replication initiation protein MCM7 [72].
In mammalian cells, RB has been localized to sites of
replication during early S phase [73], although this ﬁnding
has been disputed [74,75]. While evidence exists for non-
transcriptional cell cycle regulation by the RB pathway, the
relative importance of such regulation has been difﬁcult to
assess. Our results suggest that Chlamydomonas is an advanta-
geous model in which to address this question.
Materials and Methods
Strains and mat3 suppressor isolation. Wild-type strain 21gr and
mat3–4 mutants have been described [25]. mat3–4 suppressors were
generated as insertion mutants using the vector pSI103 [76] linearized
with NotI and transformed using the glass bead method [77] with
selection on 12 lg/ml paromomycin (Sigma, St. Louis, Missouri,
United States) on TAP plates [78]. Approximately 20,000 transformed
colonies were picked and assayed for growth and color. Those that
were faster growing and/or darker green than mat3–4 were retested
for cell size and analyzed further. All candidate mutants were crossed
to wild-type strain 6145c, and progeny were tested for linkage of the
suppressor phenotype to the pSI103 insertion. Additional details of
the insertional screen will be described elsewhere.
Vegetative diploids for dominance testing were constructed as
follows: mt
þ e2f1–1 mat3–4 was crossed to mt
  mat3–5 (an mat3 null
allele marked by paromomycin resistance) to obtain mt
  e2f1–1 mat3–
5 recombinants whose genotypes were conﬁrmed using PCR-based
markers. mt
  e2f1–1 mat3–5 or mt
  E2F1 mat3–5 strains (both
paromomycin resistant) were mated to mt
þ E2F1 mat3–4 (marked by
emetine resistance), and vegetative diploids ( mt
þ/mt
  e2f1–1/E2F1
mat3–4/mat3–5 or mt
þ/mt
  E2F1/E2F1 mat3–4/mat3–5) were selected on
TAP plates containing 15 lg/ml paromomycin and 60 lg/ml emetine
(Sigma) [79,80]. The presence of both mating locus alleles and mutant
or wild-type alleles of MAT3 and E2F1 was conﬁrmed using PCR on
selected diploids [81].
Culture conditions and synchronization. Chlamydomonas reinhardtii
cells were grown in 500-ml Erlenmeyer ﬂasks in 300 ml of inorganic
high-salt medium (HSM) [78] aerated with 0.5% CO2 in air with 250
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 1 illumination at 24 8C. Otherwise cultures were
maintained on TAP plates with 1.5% agar [78].
For dark-shift experiments, cells were grown in continuous light
for 2 to 3 d with density maintained at 10
5 to 10
6 cells/ml and then
transferred into the dark for 16 to 18 h.
Synchrony was induced using the following regimens (Figures 4, 7,
and 9): wild-type, e2f1–1, e2f1–1 mat3–4, and dp1–1 mat3–4 in 12:12 h
light/dark for several weeks (until a high level of synchrony was
achieved), followed by transfer to 11:13 h light/dark for several weeks
and, through sampling; dp1–1 in 9:15 h light/dark for several weeks
(until a high level of synchrony was achieved) followed by 11:13 h
light/dark for several weeks and through sampling. Note that all the
strains were well equilibrated in an 11:13 light/dark regimen prior to
and during the experiments (Figure 8). Wild-type and mat3–4 cultures
were grown in continuous light and dark-shifted as described above.
The cultures were then returned to the light to resume growth
(Figure 9A). Wild-type cells were maintained in a 12:12 h light/dark
regimen.
For transcriptional inhibition a-amanitin (Axxora LLC, San Diego,
California, United States) was added to synchronized wild-type or
dp1–1 cultures at 9 or 8 h in the light period, respectively. For dose-
response experiments (Figure 9C and 9D), the cultures were
immediately dark-shifted for 18 h, and daughter cell sizes were
measured as described below.
Cell size and cell cycle analysis. Photomicroscopy was performed
using a Deltavision DV3000 system with a 360 objective and DIC
prisms (Applied Precision, Seattle, Washington, United States).
Cell size was determined using samples ﬁxed with 0.2% gluta-
raldehyde/0.005% Tween 20 and measured using a Coulter Counter
(MULTISIZER 3; Beckman-Coulter, Miami, Florida, United States).
Mitotic index and the plate-based Commitment assay were as
described previously [25]. Commitment size was measured as
described in Figure 3 and Table 1 legends.
For ﬂow cytometry, 10 ml of cells was pelleted in the presence of
0.005% Tween 20 and ﬁxed by resuspending in 10 ml of ethanol/
acetic acid (3:1) for 1 h at room temperature. Fixed cells were
repelleted and washed once with FACS buffer (0.2 M Tris [pH 7.5], 20
mM EDTA), resuspended in 1 ml of FACS buffer, and stored at 4 8C.
Prior to ﬂow cytometry, cells were incubated in FACS buffer at 37 8C
with 100 lg/ml RNase A for 2 h, washed once with PBS, and
resuspended in 1 ml of PBS. DNA was stained with Sytox Green
(Invitrogen, Carlsbad, California, United States) diluted 1:10,000, and
cytometry was performed with a FACScan system (Becton-Dickinson,
Palo Alto, California, United States).
Isolation of a genomic DP1 clone and complementation of dp1–1.
Wild-type genomic DNA was double digested with KpnI and BglII
(New England Biolabs, Beverly, Massachusetts, United States). A mini-
library of approximately 4-kb fragments was generated by ligation
into pBluescript SK
 , and colony lifts were probed with DP1
sequences (as above). One positive clone (pDP1) was sequenced and
used to generate pDP1-ble by inserting the HindIII-digested ble
marker from pSP124 [82] into the SpeI site in the polylinker of pDP1.
The DP1-ble cassette was isolated from pDP1-ble as a KpnI-XhoI
fragment and used to transform a dp1–1 mat3–4 strain using Zeocin
selection (5 lg/ml) (Invitrogen). Complemented transformants with
mat3–4–sized cells were crossed to a wild-type strain (6145c) in order
to segregate away the mat3–4 mutation and to conﬁrm linkage of the
Zeocin resistance and complementation phenotypes.
Isolation and characterization of e2f1–4. e2f1–4 was isolated during
transformation of an mat3–4 nit1–305 strain [25] with an NIT1-
containing vector. The inserted NIT1 DNA in the suppressed
transformant was found to be linked to the suppression phenotype
and located approximately 10 kb from the E2F1 locus whose DNA was
then sequenced to identify the e2f1–4 deletion. The deletion removes
approximately 1.1 kb of the genomic locus from nucleotides 1124 to
2243 (numbered from the initiator ATG) (corresponding to nucleo-
tides 463 to 1221 of the E2F1 cDNA) and would generate an in-frame
deletion that removes exon 5 and fuses exons 4 and 6. The predicted
E2F1–4 protein would be missing amino acids 155 to 407. The library
used to isolate e2f1–4 genomic DNA was made using the kBlueSTAR
Vector System (Novagen, Madison, Wisconsin, United States) accord-
ing to the manufacturer’s instructions. Plaque lifts from the library
were probed with E2F1 sequences and positive clones containing
e2f1–4 were isolated and conﬁrmed by sequencing. An approximately
4-kb e2f1–4 genomic fragment was isolated from a positive phage
clone by PspOMI digestion and cloned into the vector pLitmus 38
(New England Biolabs) that had an aphVIII cassette encoding
paromomycin resistance to generate pE2F1–4. The aphVIII cassette
was a PvuII-SpeI fragment from pSI103 that had been inserted into
the HpaI site of pLitmus 38. pE2F1–4 or control plasmid pSI103 was
used to transform an mat3–4 strain using paromomycin selection (25
lg/ml), and several suppressed clones were chosen from the pE2F1–4
mat3–4 transformants. Two of the suppressed mat3–4 transformants
were crossed to a wild-type strain (6145c), and the linkage of the cell
size phenotype and the paromomycin resistance phenotype was
conﬁrmed in the progeny.
Quantitative RT-PCR. Approximately 1.5310
7 cells were pelleted
at each time point, ﬂash-frozen in liquid nitrogen, and stored at  70
8C. For mat3–4, 4.5 to 5 3 10
7 cells were collected. RNA was isolated
using TRIzol (Invitrogen) according to the manufacturer’s instruc-
tion. The puriﬁed RNA was treated with RNase-free DNase (Qiagen,
Valencia, California, United States) followed by RNeasy mini-column
puriﬁcation (Qiagen) according to the manufacturer’s instructions.
Total RNA 5 lg was used for cDNA synthesis. cDNA was
synthesized at 55 8C for 70 min using ThermoScript RT-PCR
(Invitrogen) according to the manufacturer’s instructions and using
a mixture of dT and random primers (9:1 ratio). Real-time RT-PCR
analysis was carried out using a Bio-Rad iCycler iQ (Hercules,
California, United States). Each 20-ll RT-PCR contained 0.25 llo f
cDNA, 13 ExTaq buffer (Takara, Shiga, Japan), 13 SYBR Green I
(Invitrogen), 10 nM ﬂuorescein (Bio-Rad), 0.1% Tween 20, 0.1 mg/ml
BSA, 5% DMSO, 200 lM dNTPs, 1 lM primers, and 10 units of Taq
polymerase. The following program was used for ampliﬁcation: 94 8C
for 3 min, 40 cycles of 94 8C for 10 s, and 60 8C for 30 s. PCR was
performed in triplicate, and the experiments were repeated twice
with RNA isolated from independent cultures. A melting curve of
each PCR was examined to ensure that no primer-dimers or spurious
products were present.
Southern blot analyses. Genomic DNA preparation and Southern
blotting were carried out as previously described [24]. Probes were
derived from PCR-ampliﬁed cDNA using primers 59-CCAT-
GAAGGTGTGCGAAAAGG-39 and 59-CTGCACGTCCAT-
CATGTCGTC-39 for DP1,a n dp r i m e r s5 9-
CTGAAACGTTGAAGGTCCAAA-39 and 59-ACCAGGTACACGTC-
GATGG-39 for E2F1.
Supporting Information
Figure S1. Southern Blot of Genomic DNA from Different Strains
(Indicated above Each Lane) Digested with SmaI and Probed with
DP1 or E2F1 DNA
dp1–1 contains an insertion in the DP1 locus. dp1–3,  4 ,-6,  7,  8
alleles have deletions that remove DP1 and some ﬂanking sequence.
e2f1–1,  2,  3 contain insertions in a 1.4-kb SmaI fragment depicted
in Figure 1B.
Found at DOI: 10.1371/journal.pgen.0020167.sg001 (690 KB TIF).
Figure S2. Assessment of DP1 and E2F1 Copy Number by Low-
Stringency Southern blotting
(A) Restriction maps of DP1 and E2F1 genomic DNA. The predicted
DNA fragments digested with BamHI, NheI, or SmaI are indicated.
(B) Low-stringency Southern blot of wild-type genomic DNA digested
with BamHI (B), NheI (N), or SmaI (S) and probed with cDNA
fragments corresponding to the conserved N-terminal regions of DP1
or E2F1. Low-stringency blotting was carried out as previously
described [24].
Found at DOI: 10.1371/journal.pgen.0020167.sg002 (1.3 MB TIF).
Figure S3. Cell Size and Semiquantitative RT-PCR Analysis of dp1–3,a
Deletion Allele
(A) Size distribution of dark-shifted cultures from indicated the
genotypes.
(B) RT-PCR of MCM2, RNR1, PCN1, POLA4, CYCA1, CYCB1, CDKB1,
and TUA1 in unsynchronized light-grown cultures of the indicated
genotype as described in [24]. a-Tubulin (TUA1) serves as the internal
control. The percent mitotic state indicates what fraction of cells in
the culture were mitotic when the sample was taken for RNA
preparation. The mitotic fraction was higher for the dp1 mutants
compared to wild-type and explains the increased abundance of cell
cycle messages in the mutant strains compared to the wild-type
control.
Found at DOI: 10.1371/journal.pgen.0020167.sg003 (837 KB TIF).
Figure S4. Expression Patterns of CYCA1, CYCB1, CDC6, PCN1, RIR1,
MCM2, and HFO in Synchronized Cultures of Indicated Genotype
The samples are from the same cultures as in Figure 7.
Found at DOI: 10.1371/journal.pgen.0020167.sg004 (688 KB TIF).
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Size Control by the RB PathwayFigure S5. Expression Patterns of CYCB1, CDC6, PCN1, RIR1, MCM2, and
HFO in Partially Synchronized Cultures of Wild-Type and mat3–4 Strains
The samples used are the same as in Figure 8.
Found at DOI: 10.1371/journal.pgen.0020167.sg005 (298 KB TIF).
Table S1. List of Primers for Quantitative RT-PCR
Found at DOI: 10.1371/journal.pgen.0020167.st001 (21 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
bers for DP1 and E2F1 are DQ417491 and DQ417492.
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